RecruitingNCT07240350

The Role and Regulatory Mechanism of Germinal Center Immune Response in Hepatitis B Virus Infection


Sponsor

Nanfang Hospital, Southern Medical University

Enrollment

280 participants

Start Date

Jan 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this observational study is to investigate the structure and composition of germinal centers in individuals with chronic HBV infection. The primary questions it aims to address are: What are the phenotypes, functions, and complexity of B cell clones of the immune cells within the germinal centers of chronic HBV-infected individuals? Do chronic HBV-infected individuals have ectopic germinal centers in the liver? This will be studied by collecting peripheral blood and discarded liver, lymph node, and tonsil tissues from chronic HBV patients undergoing lymph node surgery, hepatectomy, and tonsillectomy.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This research study is investigating how the immune system — specifically a structure called the germinal center — responds during chronic hepatitis B virus (HBV) infection. Researchers will collect tissue samples from liver, spleen, tonsil, or lymph node surgeries to better understand why some people clear the virus while others develop chronic infection. **You may be eligible if...** - You have been diagnosed with chronic hepatitis B virus infection - You need surgery on your liver, spleen, tonsils, or lymph nodes as part of your medical care - You understand the study process and are willing to provide written consent **You may NOT be eligible if...** - You also have hepatitis C, HIV, alcoholic liver disease, non-alcoholic fatty liver disease, or autoimmune liver disease - You have an immune system disorder or blood clotting condition Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETissue resection

The group of HBV patients who underwent liver, spleen, tonsil, and lymph node surgery and the group of HBV-negative patients who underwent liver, spleen, tonsil, and lymph node surgery


Locations(1)

Nanfang hospital, Southern Medical university

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07240350


Related Trials